A robot scientist for drug design and chemical genetics

  • Ross Donald King

Press/Media: Media coverage

Description

Interview on Breakfast show of BBC Radio Cambridgeshire. This related to our discovery, in work funded by the BBSRC and the Bill & Melinda Gates Foundation, that triclosan (an antimicrobial commonly used in toothpaste) had a second enzyme target in the malaria parasite. This opens up the prospect of the development of a dual-action antimalarial drug.The pair describing this work: 

Period01 Jan 2018

Media contributions

2

Media contributions

  • TitleA robot scientist for drug design and chemical genetics
    Degree of recognitionRegional
    Media name/outletBBC- Cambridge Breakfast Show
    Media typeRadio
    Country/TerritoryUnited Kingdom of Great Britain and Northern Ireland
    Date01 Jan 2018
    DescriptionInterview on Breakfast show of BBC Radio Cambridgeshire. This related to our discovery, in work funded by the BBSRC and the Bill & Melinda Gates Foundation, that triclosan (an antimicrobial commonly used in toothpaste) had a second enzyme target in the malaria parasite. This opens up the prospect of the development of a dual-action antimalarial drug.The pair describing this work: Bilsland E, van Vliet L, Williams K, Feltham J, Carrasco MP, Fotoran WL, Cubillos EFG, Wunderlich G, Grøtli M, Hollfelder F, Jackson V, King RD, Oliver SG (2018) Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan. Scientific Reports 8: 2018 (8 pages) has (thus far) an Altmetrics score of 1019 and has engendered 131 News articles.
    PersonsRoss Donald King
  • TitleA robot scientist for drug design and chemical genetics
    Degree of recognitionNational
    Media name/outletBBC Naked Science
    Media typeRadio
    Country/TerritoryUnited Kingdom of Great Britain and Northern Ireland
    Date01 Jan 2018
    PersonsRoss Donald King
View all 2
View less

Related content